LLY · News · 20260808N
Guidance and Outlook
ELI LILLY & Co · 2026-08-08 · Importance 77 · Surprise 92 · In source text
Eli Lilly reported 48% year-over-year revenue growth in the second quarter of 2026. Growth was primarily driven by continued demand for MOUNJARO and ZEPBOUND. The company raised its full-year 2026 revenue and earnings guidance, indicating a more favorable management outlook.
Key facts
- Eli Lilly raised its full-year revenue and earnings guidance. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Eli Lilly raised its full-year revenue and earnings guidance. |
| net_income | positive | probable | — | Eli Lilly raised its full-year revenue and earnings guidance. |